Kalie Tommerdahl

10PUBLICATIONS
66CO-AUTHORS
Molecular targetsInfant and child healthAdolescent healthDigital electronic devicesMedical biochemistry - carbohydrates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 22, 2026
SGLT2 inhibition modulates metabolic, vascular, and inflammatory molecular markers in the kidney in youth with type 1 diabetes.

|Feb 23, 2026
Integrating the Novel iCARE Estimated Glomerular Filtration Rate Equation for Youth Living With Type 2 Diabetes Into Care: Program Report.

Allison B Dart, J Grace Zhou, Elizabeth A C Sellers

|Sep 09, 2024
Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth.

Fida Bacha, Tamara S Hannon, Mustafa Tosur

|Oct 24, 2022
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits.

Meghan E Pauley, Kalie L Tommerdahl, Janet K Snell-Bergeon

|Jan 06, 2021
Impact of Obesity on Measures of Cardiovascular and Kidney Health in Youth With Type 1 Diabetes as Compared With Youth With Type 2 Diabetes.

Kalie L Tommerdahl, Karl Baumgartner, Michal Schäfer

|Nov 25, 2020
Results from the Effects of MEtformin on cardiovasculaR function in AdoLescents with type 1 Diabetes (EMERALD) study: A brief report of kidney and inflammatory outcomes.

Kalie L Tommerdahl, Petter Bjornstad, Jessica Kendrick

Pageof 2

Frequent Collaborators

4 joint publications

Petter Bjornstad

4 joint publications

Kristen J Nadeau

3 joint publications

Robert G Nelson

2 joint publications

Melanie Cree-Green